HIT Director Reports 5,730 Restricted Shares at $3.49; Ownership 68,735

Rhea-AI Filing Summary

Insider transactions by Director Sanjay K. Shrestha at Health In Tech, Inc. (HIT). The form reports a disposition of 65,469 Class A common shares on 10/03/2025 that were restricted shares subject to forfeiture tied to the annual stockholders meeting. The filing also shows an acquisition of 5,730 restricted Class A shares on 10/08/2025 at a purchase price of $3.49 per share; those restricted shares vest quarterly from the grant date with continued service. After these transactions the reporting person beneficially owned 68,735 Class A shares on a direct basis.

Positive

• Acquisition of 5,730 restricted shares at $3.49 on 10/08/2025, increasing aligned ownership
• Beneficial ownership of 68,735 shares on a direct basis after the transactions, showing continued stake

Negative

• Disposition of 65,469 restricted shares on 10/03/2025 due to forfeiture conditions at the annual meeting
• New restricted shares vest quarterly, so ownership is subject to forfeiture if service conditions lapse

Insights

Corporate Governance Analyst

Director sold forfeitable restricted shares and acquired new restricted stock that vests quarterly.

The reported disposition of 65,469 restricted shares on 10/03/2025 reflects shares that were subject to pro‑rata forfeiture tied to the issuer's annual meeting; this is an administrative settlement of forfeitable awards rather than an open‑market sale. The reporting person subsequently purchased 5,730 restricted shares on 10/08/2025 at $3.49 per share under the company's equity incentive plan.

Key dependencies and near‑term items to watch include the quarterly vesting schedule for the new restricted shares and any future Form 4s that disclose market sales or option exercises; these will change direct beneficial ownership levels over the next quarters as vesting occurs.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Shrestha Sanjay K

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	5,730	$3.49	$20K
Disposition	Class A Common Stock	65,469	$0.00	--

Holdings After Transaction: Class A Common Stock — 68,735 shares (Direct)

Footnotes (1)

1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date. Includes 5,730 shares of restricted stock and 63,005 shares of Class A Common Stock.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shrestha Sanjay K

(Last) (First) (Middle)

701 S. COLORADO AVE

SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/03/2025		D		65,469(1)	D	$0	63,005	D
Class A Common Stock	10/08/2025		A		5,730(2)	A	$3.49	68,735(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan, which were subject to forfeiture on a pro-rata basis upon the issuer's annual stockholders meeting held on October 3, 2025.

2. Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest quarterly commencing upon the date of grant, subject to the reporting person's continuous service through the vesting date.

3. Includes 5,730 shares of restricted stock and 63,005 shares of Class A Common Stock.

	By Sanjay Shrestha /s/ Sanjay Shrestha	10/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What trades did Health In Tech (HIT) director Sanjay Shrestha report?

The director reported a disposition of 65,469 restricted Class A shares on 10/03/2025 and an acquisition of 5,730 restricted Class A shares on 10/08/2025 at $3.49 per share.

Why were 65,469 shares disposed on 10/03/2025?

Those shares were restricted shares subject to pro‑rata forfeiture upon the issuer's annual stockholders meeting held on 10/03/2025, per the filing explanation.

How many shares does the reporting person own after these transactions?

After the reported transactions the reporting person beneficially owned 68,735 Class A common shares on a direct basis.

What are the vesting terms for the newly acquired restricted shares?

The 5,730 restricted shares vest quarterly commencing on the grant date, contingent on the reporting person's continuous service through each vesting date.

Was the acquisition an open‑market purchase or an award under a plan?

The acquisition represents restricted shares granted under the Health In Tech Equity Incentive Plan, not an open‑market purchase, and the filing notes they are subject to vesting and service conditions.